Form 8-K - Current report:
SEC Accession No. 0001753926-25-000312
Filing Date
2025-02-27
Accepted
2025-02-27 16:30:35
Documents
17
Period of Report
2025-02-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K g084715_8k.htm   iXBRL 8-K 25131
2 EXHIBIT 10.1 g084715_ex10-1.htm EX-10.1 32735
3 GRAPHIC img001.jpg GRAPHIC 7348
4 GRAPHIC img002.jpg GRAPHIC 1033
5 GRAPHIC img003.jpg GRAPHIC 1917
  Complete submission text file 0001753926-25-000312.txt   250093

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ivbt-20250223.xsd EX-101.SCH 3033
7 XBRL LABEL FILE ivbt-20250223_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE ivbt-20250223_pre.xml EX-101.PRE 22371
19 EXTRACTED XBRL INSTANCE DOCUMENT g084715_8k_htm.xml XML 3346
Mailing Address 179 RTE 46W, SUITE 15 #147 ROCKAWAY NJ 07866
Business Address 179 RTE 46W, SUITE 15 #147 ROCKAWAY NJ 07866 929-459-4966
Innovation1 Biotech Inc. (Filer) CIK: 0001629205 (see all company filings)

EIN.: 822275255 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 000-55852 | Film No.: 25679575
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)